Company Pro Life Pharma Srl with Fiscal Code 19206843
recorded a turnover of 2024 of
1.637.425,
with a net profit of
108.190
and having an average number of employees of
12.
The company operates in the field of Comerţ cu ridicata al produselor cosmetice şi de parfumerie having the NACE code 4645.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Pro Life Pharma Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
629.838
763.031
804.278
922.337
1.039.822
978.073
1.180.250
999.940
1.259.388
1.637.425
Total Income - EUR
637.807
774.035
806.473
930.281
1.046.126
1.005.021
1.383.150
1.097.260
1.291.098
1.664.257
Total Expenses - EUR
613.993
650.094
735.270
794.288
942.102
854.850
1.145.251
1.084.575
1.260.819
1.538.545
Gross Profit/Loss - EUR
23.814
123.940
71.203
135.993
104.025
150.171
237.899
12.685
30.279
125.712
Net Profit/Loss - EUR
23.814
123.940
71.203
126.789
93.583
131.233
215.233
2.479
14.486
108.190
Employees
12
12
13
2
13
12
11
10
11
12
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 30.7%, from 1.259.388 euro in the year 2023, to 1.637.425 euro in 2024.
The Net Profit increased by 93.785 euro, from 14.486 euro in 2023, to 108.190 in the last year.
Check the financial reports for the company - Pro Life Pharma Srl
Financial Rating - PRO LIFE PHARMA SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Pro Life Pharma Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Pro Life Pharma Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Pro Life Pharma Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Pro Life Pharma Srl - CUI 19206843
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
30.016
60.901
48.540
36.799
116.958
260.448
283.656
333.564
266.898
189.821
Current Assets
198.793
253.694
299.673
351.774
361.271
363.245
558.124
409.166
445.592
607.955
Inventories
68.838
90.937
92.175
112.577
131.794
144.418
162.047
109.250
159.351
188.733
Receivables
124.246
140.371
168.432
193.961
188.583
168.398
212.305
214.868
224.504
233.240
Cash
5.709
22.386
39.066
45.235
40.894
50.430
183.773
85.048
61.737
185.983
Shareholders Funds
-225.109
-98.272
-25.406
101.850
193.460
321.026
529.139
348.987
362.366
346.134
Social Capital
67
668
657
645
632
620
606
811
809
804
Debts
456.325
415.442
375.312
290.760
291.711
245.826
227.247
306.344
287.389
411.208
Income in Advance
0
0
0
0
0
63.881
92.105
97.790
72.324
46.891
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"4645 - 4645"
CAEN Financial Year
4645
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
607.955 euro in 2024 which includes Inventories of
188.733 euro, Receivables of
233.240 euro and cash availability of
185.983 euro.
The company's Equity was valued at
346.134 euro, while total Liabilities amounted to
411.208 euro.
Equity decreased by -14.207 euro, from 362.366 euro in 2023, to 346.134 in 2024.
The Debt Ratio was 51.1% in the year 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Pro Life Pharma Srl